Align Technology (NASDAQ:ALGN) beats Q3 2026 sales expectations but quarterly revenue guidance misses expectations
Align Technology reported Q3 2026 revenue of $1.01 billion, beating estimates by 1.1%, with adjusted EPS of $2.80, a 1.3% beat. Adjusted operating income was $247.8 million, a 3.4% beat. However, Q4 2026 revenue guidance of $1.01 billion missed estimates of $1.05 billion. Operating margin improved to 16.7% from 9.7% year-on-year, with sales volumes up 6.6%.
How this was made
The 30-second read
Why it matters
The mixed results create a nuanced market reaction: short-term rally on beat, followed by sell pressure on guidance miss.
Market read
Earnings release is the primary catalyst for ALGN's stock movement, with guidance miss likely driving near-term downside.
What to watch
Potential upside from upcoming product launches and international expansion not reflected in the guidance.
Background
Align Technology reported Q3 2026 results with revenue of $1.01B and EPS of $2.80, both beating estimates, but forecast Q4 revenue of $1.01B, below consensus of $1.05B.
Ticker impact
Q3 2026 earnings beat on revenue and EPS but Q4 revenue guidance missed consensus estimates.
likely downside pressure as the market prices in the guidance shortfall
Investors reward the beat but penalize the lower-than-expected Q4 outlook, prompting a net negative bias.
Market effects
Dental and orthodontic device sector may see modest pullback as peers' guidance expectations tighten.
U.S. market sentiment could dip slightly in the healthcare equipment segment.
Limited; impact confined to U.S. listed dental device companies.
Counterpoint
The beat on current quarter could outweigh guidance miss if the market underestimates long-term growth from new product pipelines.
Key entities
- companyAlign Technology
Provider of Invisalign and iTero intraoral scanners.
